CyberKnife’s Higher Doses of Radiotherapy Cuts Treatment Time by up to 75% for Prostate Cancer Patients While Maintaining High Cure Rates

People with low to medium-risk, localized prostate cancer can be treated as effectively using fewer and higher doses of radiation therapy delivered over five treatment sessions as they can with lower doses delivered over several weeks, according to researchers from...

Combining SBRT to Standard Therapy for Metastatic Prostate Cancer Significantly Improves Outcome

Combining stereotactic body radiation therapy (SBRT), such as CyberKnife with standard systemic therapy yielded significant increases in the rates of biochemical response and progression-free survival (PFS) in patients with oligometastatic castrate-resistant prostate...